Germany's Fielmann Q3 sales rise year on year, maintains 2026 outlook

By Reuters News


Overview

  • Germany's vision care provider Q3 sales rose 5.1% yr/yr to €649 mln

  • Company opened 19 new locations in Q3, supporting international sales growth

  • Adjusted EBITDA margin held at 23.4% for first nine months


Outlook

  • Fielmann confirms full-year 2026 guidance updated in August

  • Company expects 2026 sales of €2.50 bln to €2.55 bln, up 2% to 5% YoY

  • Fielmann sees 2026 adjusted EBITDA at €560 mln to €580 mln, margin 22% to 23%


Result Drivers

  • PRICE LEADERSHIP - Co said value-focused pricing drove unit growth in existing stores

  • NETWORK EXPANSION AND AUDIOLOGY - New store openings and audiology segment growth supported sales

  • TECHNOLOGY ROLLOUT - AI-based automated refraction technology improved capacity and productivity


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Slight Miss*

EUR 649 mln

EUR 649.80 mln (2 Analysts)

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the miscellaneous specialty retailers peer group is "buy"

  • Wall Street's median 12-month price target for Fielmann Group AG is €55.00, about 32.9% above its November 4 closing price of €41.40

  • The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 15 three months ago


Reuters Recommended Reads

  • Nov 2 - Ireland's Ryanair H1 profit falls 15% as fuel costs rise

  • Nov 4 - UK's Marks and Spencer interim revenue, profit beat estimates

  • Nov 4 - Pandora Q3 organic revenue rises on APAC growth, narrows guidance


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.